Allergan plcAGN recently announced that its marketed drug Restasis (cyclosporine ophthalmic emulsion) 0.05% is now available in multidose bottles in the U.S. It is the first and only prescription ...

Note: If you use other eye drops in addition to Restasis, you can probably still use those drops while you’re using Restasis. But make sure to check with your doctor about which eye drops are safe to ...

Please provide your email address to receive an email when new articles are posted on . Allergan announced it has received FDA approval for Restasis Multidose, a preservative-free, multidose bottle ...

It’s not exactly going to be smooth sailing for Allergan’s multidose bottle version of dry-eye med Restasis. As it finally gets the green light from the FDA, a new challenge named Xiidra lies ahead.

DUBLIN, March 10, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its Prior Approval ...

Restasis, a calcineurin inhibitor immunosuppressant, helps increase the eyes' natural ability to produce tears in patients whose tear production is presumed to be suppressed due to ocular inflammation ...

MARKHAM, ON, June 7, 2018 /CNW/ - Allergan plc announced today that it has received approval from Health Canada for RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic Emulsion) 0.05%. RESTASIS MULTIDOSE™ is ...

You may qualify for free Restasis through the drug’s manufacturer, myAbbVie Assist. That said, you won’t use your Medicare coverage. Restasis (cyclosporine), a brand-name eye drop for chronic dry eyes ...

Please provide your email address to receive an email when new articles are posted on . Allergan announced that Restasis Multidose 0.05% has received approval from Health Canada. “Restasis Multidose ...

The FINANCIAL — Allergan plc announced on November 11 that it has submitted a Prior Approval Supplement (PAS) for RESTASIS (Cyclosporine Ophthalmic Emulsion) 0.05%, seeking approval of a Multi-Dose ...

Allergan plc AGN recently announced that its marketed drug Restasis (cyclosporine ophthalmic emulsion) 0.05% is now available in multidose bottles in the U.S. It is the first and only prescription ...